Antithrombotic therapy in infective endocarditis: Long-term clinical outcomes of a retrospective cohort study
In this retrospective cohort, anticoagulated patients did not show a higher rate of adverse events during hospitalization and had a lower long-term event rate. These findings represent correlations observed in a non-randomized, single-center setting and may partly reflect differences in underlying risk profiles and treatment selection (confounding by indication and residual confounding). Prospective studies are needed to confirm any causal effects and to define more precisely the role of ATT in patients with IE and elevated cardiovascular risk.
Authors
- Samuel Tobias Sossalla (ORCID: https://orcid.org/0000-0001-8034-2673)
- Florian Hitzenbichler (ORCID: https://orcid.org/0000-0003-4374-2787)
- Christian Schach (ORCID: https://orcid.org/0000-0001-9560-4015)
- Felix Schlachetzki (ORCID: https://orcid.org/0000-0001-6167-2597)
- Jozef Micek
- K Debl
- Elias Füssl
- Kostiantyn Kozakov
- Firat Koyun
- Carlotta Posner
- Henrik Heuer
- Hiba Daas
- Lukas Krämer
Institutions
- Justus-Liebig-Universität Gießen (DE)
- University Hospital Regensburg (DE)
- Kerckhoff Klinik (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1007/s00392-026-02859-w
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universität Regensburg